| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.098 | 0.008 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.09 | 0.008 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.009 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.009 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.098 | 0.009 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.072 | 0.009 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.14 | 0.009 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |